angiotensin ii has been researched along with pentoxifylline in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (8.33) | 18.7374 |
| 1990's | 2 (16.67) | 18.2507 |
| 2000's | 3 (25.00) | 29.6817 |
| 2010's | 3 (25.00) | 24.3611 |
| 2020's | 3 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cryer, HG; Flynn, WJ; Garrison, RN | 1 |
| Hakim, TS; Petrella, J | 1 |
| Aso, T; Bronson, RA; Kubota, T; Maruyama, Y; Shimizu, Y; Yorimitsu, A | 1 |
| Bolick, DT; Hatley, ME; Hedrick, CC; Nadler, JL; Srinivasan, S | 1 |
| Chen, RH; Chen, YM; Chiang, WC; Lai, CF; Lin, SL; Tsai, TJ; Wu, KD | 1 |
| Felder, RB; Kang, YM; Weiss, RM; Xue, B; Zhang, ZH | 1 |
| Azhar, A; El-Bassossy, HM | 1 |
| Chen, Y; Dong, P; Li, D; Li, L; Meng, F; Song, J; Wang, J; Yang, B; Zhang, L; Zhang, X | 1 |
| Beltz, TG; Felder, RB; Guo, F; Johnson, AK; Wei, SG; Xue, B; Yu, Y | 1 |
| Fang, ZQ; Huo, YL; Johnson, AK; Li, JD; Peng, W; Wang, HP; Wang, XF; Xue, B; Zhang, YP | 1 |
| Ali, FEM; Bakr, AG; El-Bahrawy, AH; Taha, HH | 1 |
| Chávez-Alderete, J; Loza-Mejía, MA; Maldonado, V | 1 |
12 other study(ies) available for angiotensin ii and pentoxifylline
| Article | Year |
|---|---|
Pentoxifylline but not saralasin restores hepatic blood flow after resuscitation from hemorrhagic shock.
Topics: Angiotensin II; Animals; Blood Pressure; Cardiac Output; Liver Circulation; Pentoxifylline; Rats; Resuscitation; Saralasin; Shock, Hemorrhagic | 1991 |
Attenuation of pulmonary and systemic vasoconstriction with pentoxifylline and aminophylline.
Topics: Aminophylline; Angiotensin II; Animals; Dogs; Hemodynamics; Hypoxia; Lung; Pentoxifylline; Swine; Theobromine; Vascular Resistance; Vasoconstriction | 1988 |
Prostaglandins induce calcium influx in human spermatozoa.
Topics: Acrosome; Adult; Alprostadil; Angiotensin II; Atrial Natriuretic Factor; Body Fluids; Calcium; Calcium Channel Blockers; Calcium Channels; Culture Media; Cyclic AMP; Dihydropyridines; Dinoprost; Dinoprostone; Drug Interactions; Endothelin-1; Female; Humans; Infertility, Male; Ion Transport; Male; Ovarian Follicle; Pentoxifylline; Pertussis Toxin; Progesterone; Sperm Capacitation; Sperm-Ovum Interactions; Spermatozoa; Virulence Factors, Bordetella | 1998 |
Lisofylline, a novel antiinflammatory compound, protects mesangial cells from hyperglycemia- and angiotensin II-mediated extracellular matrix deposition.
Topics: Angiotensin II; Anti-Inflammatory Agents, Non-Steroidal; Cells, Cultured; Connective Tissue Growth Factor; Cyclic AMP Response Element-Binding Protein; Extracellular Matrix; Extracellular Matrix Proteins; Fibronectins; Gene Expression; Glomerular Mesangium; Glucose; Humans; Hyperglycemia; Immediate-Early Proteins; Intercellular Signaling Peptides and Proteins; MAP Kinase Signaling System; Mitogen-Activated Protein Kinases; p38 Mitogen-Activated Protein Kinases; Pentoxifylline; Phosphorylation; Transforming Growth Factor beta; Vasoconstrictor Agents | 2003 |
Pentoxifylline attenuates tubulointerstitial fibrosis by blocking Smad3/4-activated transcription and profibrogenic effects of connective tissue growth factor.
Topics: Actins; Angiotensin II; Animals; Cell Line; Collagen Type I; Connective Tissue Growth Factor; Fibrosis; Gene Expression; Immediate-Early Proteins; Intercellular Signaling Peptides and Proteins; Kidney; Male; Models, Biological; Pentoxifylline; Rats; Rats, Wistar; Signal Transduction; Smad3 Protein; Smad4 Protein; Transcriptional Activation; Transforming Growth Factor beta; Transforming Growth Factor beta1; Ureteral Obstruction | 2005 |
Inhibition of brain proinflammatory cytokine synthesis reduces hypothalamic excitation in rats with ischemia-induced heart failure.
Topics: Action Potentials; Adrenocorticotropic Hormone; Angiotensin II; Animals; Anti-Inflammatory Agents; Cyclooxygenase 2; Cytokines; Dinoprostone; Disease Models, Animal; Heart Failure; Hypothalamo-Hypophyseal System; Hypothalamus; Inflammation Mediators; Infusions, Parenteral; Interleukin-1beta; Male; Myocardial Ischemia; Norepinephrine; Paraventricular Hypothalamic Nucleus; Pentoxifylline; Pituitary-Adrenal System; Proto-Oncogene Proteins c-fos; Rats; Rats, Sprague-Dawley; Renin-Angiotensin System; Superoxides; Tumor Necrosis Factor-alpha; Ultrasonography | 2008 |
Pentoxifylline alleviates hypertension in metabolic syndrome: effect on low-grade inflammation and angiotensin system.
Topics: Angiotensin II; Animals; Disease Models, Animal; Hypertension; Inflammation; Male; Metabolic Syndrome; Pentoxifylline; Rats; Rats, Wistar; Receptor, Angiotensin, Type 1; Vasodilator Agents | 2015 |
Pentoxifylline Ameliorates Cardiac Fibrosis, Pathological Hypertrophy, and Cardiac Dysfunction in Angiotensin II-induced Hypertensive Rats.
Topics: Angiotensin II; Animals; Cardiomegaly; Fibrosis; Hypertension; Inflammation Mediators; Male; Pentoxifylline; Phosphodiesterase Inhibitors; Rats; Rats, Sprague-Dawley | 2016 |
Stress-Induced Sensitization of Angiotensin II Hypertension Is Reversed by Blockade of Angiotensin-Converting Enzyme or Tumor Necrosis Factor-α.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Brain; Captopril; Cytokines; Disease Models, Animal; Hypertension; Inflammation Mediators; Male; Microglia; Pentoxifylline; Rats, Long-Evans; Rats, Sprague-Dawley; Renin-Angiotensin System; Stress Disorders, Post-Traumatic; Tumor Necrosis Factor Inhibitors | 2019 |
Blockade of angiotensin-converting enzyme or tumor necrosis factor-α reverses maternal high-fat diet-induced sensitization of angiotensin II hypertension in male rat offspring.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animal Nutritional Physiological Phenomena; Animals; Antihypertensive Agents; Blood Pressure; Brain; Captopril; Diet, High-Fat; Disease Models, Animal; Female; Hypertension; Male; Maternal Nutritional Physiological Phenomena; Pentoxifylline; Pregnancy; Prenatal Exposure Delayed Effects; Rats, Sprague-Dawley; Renin-Angiotensin System; Tumor Necrosis Factor Inhibitors | 2020 |
Diosmin enhances the anti-angiogenic activity of sildenafil and pentoxifylline against hepatopulmonary syndrome via regulation of TNF-α/VEGF, IGF-1/PI3K/AKT, and FGF-1/ANG-2 signaling pathways.
Topics: Angiogenesis Inhibitors; Angiotensin II; Animals; Diosmin; Drug Synergism; Fibroblast Growth Factor 1; Hepatopulmonary Syndrome; Insulin-Like Growth Factor I; Male; Pentoxifylline; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Rats; Rats, Wistar; Signal Transduction; Sildenafil Citrate; Tumor Necrosis Factor-alpha; Vascular Endothelial Growth Factor A | 2020 |
Repositioning of pentoxifylline as an immunomodulator and regulator of the renin-angiotensin system in the treatment of COVID-19.
Topics: Alveolar Epithelial Cells; Angiotensin II; Angiotensin-Converting Enzyme 2; Animals; Complement Activation; COVID-19; COVID-19 Drug Treatment; Cytokines; Disease Models, Animal; Drug Repositioning; Endothelial Cells; Gene Expression Regulation; Humans; Immunologic Factors; Inflammation; Lymphocyte Subsets; Microcirculation; Oxidative Stress; Pandemics; Pentoxifylline; Rats; Receptors, Virus; Renin-Angiotensin System; SARS-CoV-2; Signal Transduction; Venous Thromboembolism | 2020 |